Susceptibilidad genética frente al cáncer bucal por infección del virus del papiloma humano

dc.contributor.authorRebolledo-Cobos, Martha
dc.contributor.authorYáñez-Torregrosa, Zuleima
dc.date.accessioned2019-06-17T21:56:23Z
dc.date.available2019-06-17T21:56:23Z
dc.date.issued2019
dc.description.abstractLos carcinógenos ambientales y el virus del papiloma humano (VPH) son los principales responsables del cáncer bucal. Los factores de susceptibilidad en el genoma humano desempeñan un papel modulador del riesgo, sin embargo, no todos los individuos expuestos a los carcinógenos padecen cáncer. El objetivo de la presente revisión es describir los principales factores de susceptibilidad genética para cáncer bucal en individuos con infección por VPH. Se realizó una búsqueda sistemática en tres bases de datos en inglés; solo siete artículos cumplieron con los criterios de selección. Se registraron polimorfismos genéticos en tres categorías relacionados con el VPH y que participan en la oncogénesis. Se identificaron tres artículos relativos a la desregulación de los mecanismos de control del ciclo celular, uno relativo a mutaciones en la vía de la apoptosis y tres a polimorfismos en genes de respuesta inflamatoria e inmune. La asociación entre polimorfismos para el desarrollo de cáncer bucal y VPH es evidente, aunque continúa en estudio ya que no siempre el patrón de oncogénesis de las neoplasias bucales está relacionado con el VPH, sino con otros factores ambientales o epigenéticos.spa
dc.description.abstractEnvironmental carcinogens and human papillomavirus (HPV) are the main responsible factors for oral cancer. Susceptibility factors in the human genome play a risk-modulating role; however not all individuals exposed to these carcinogens suffer from cancer. The purpose of the present review is to describe the main factors of genetic susceptibility to oral cancer due to HPV infection. A systematic search was carried out in three databases in English, with only 7 articles meeting the selection criteria. Genetic polymorphisms are shown in three categories, which are related to HPV and participate in oncogenesis. Three articles related to deregulation of cell cycle control mechanisms were identified, as well as one referring to mutations in the apoptosis pathway and three about polymorphisms in inflammatory and immune response genes. The association of polymorphisms for the development of oral cancer by HPV is evident, although it remains under study. Oral neoplasms’ oncogenesis pattern is not always associated with HPV, but with other environmental or epigenetic factors.eng
dc.identifier.issn00163813
dc.identifier.urihttps://hdl.handle.net/20.500.12442/3252
dc.language.isospaspa
dc.publisherAcademia Nacional de Medicina de Méxicospa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionaleng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceRevista Gaceta Médica de Méxicospa
dc.sourceVol. 155, No. 3 (2019)spa
dc.source.urihttps://doi.org/10.24875/GMM.18004408spa
dc.subjectSusceptibilidad genéticaspa
dc.subjectCáncer bucalspa
dc.subjectPolimorfismosspa
dc.subjectVirus del papiloma humanospa
dc.subjectMutaciónspa
dc.subjectGenetic susceptibilityeng
dc.subjectOral cancereng
dc.subjectPolymorphismseng
dc.subjectHuman papillomaviruseng
dc.subjectMutationeng
dc.titleSusceptibilidad genética frente al cáncer bucal por infección del virus del papiloma humanospa
dc.typearticlespa
dcterms.referencesBeaudet AL, Tsui LC. A suggested nomenclature for designating mutations. Hum Mutat. 1993;2:245-248.eng
dcterms.referencesBeutler E. The designation of mutations. Am J Hum Genet. 1993;53:783-785.eng
dcterms.referencesKarki R, Pandya D, Elston RC, Ferlini C. Defining “mutation” and “polymorphism” in the era of personal genomics. BMC Med Genomics. 2015;15;8:37.eng
dcterms.referencesLacko M, Braakhuis BJ, Sturgis EM, Boedeker CC, Suárez C, Rinaldo A, et al. Genetic susceptibility to head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2014;89:38-48.eng
dcterms.referencesHino O, Kobayashi T. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. Cancer Sci. 2017;108:5-11.eng
dcterms.referencesFamooto A, Almujtaba M, Dareng E, Akarolo-Anthony S, Ogbonna C, Offiong R, et al. RPS19 and TYMS SNPs and Prevalent high risk human papilloma virus infection in Nigerian women. PLoS One. 2013:27;8:e66930.eng
dcterms.referencesKenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, et al. Human genetic determinants of viral diseases. Annu Rev Genet. 2017;51:241-263.eng
dcterms.referencesTandon N, Srivastava AN, Fatima N, Raza ST, Kumar V. p53 codon 72 gene polymorphism studies and p53 expression by immunohistochemistry in oral lesions as risk factor for malignancy. Int J Appl Basic Med Res. 2017;7:243-246.eng
dcterms.referencesSaleem S, Azhar A, Hameed A, Khan MA, Abbasi ZA, Qureshi NR, et al. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan. Oral Oncol. 2013;49:818-823.eng
dcterms.referencesMurali A, Nalinakumari KR, Thomas S, Kannan S. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility. Br J Oral Maxillofac Surg. 2014;52:652-658.eng
dcterms.referencesSun Y, Yu W, Sturgis EM, Peng W, Lei D, Song X, et al. Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. BMC Cancer. 2016;16:70.eng
dcterms.referencesJin L, Sturgis EM, Zhang Y, Huang Z, Song X, Li C, et al. Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma. Mol Cancer. 2013;12:80.eng
dcterms.referencesHsu HJ, Yang YH, Shieh TY, Chen CH, Kao YH, Yang CF, et al. TGF-b1 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese. Kaohsiung J Med Sci. 2015;31:123-129.eng
dcterms.referencesAntonsson A, Law MH, Neale RE, Coman WB, Pryor DI, Whiteman DC, et al. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck. Cancer Causes Control. 2016;27:809-815.geng

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
PDF.pdf
Tamaño:
195.48 KB
Formato:
Adobe Portable Document Format
Descripción:
PDF
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
368 B
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones